Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Inhibitory potency

Generic name Trade name Manufacturer Year of introduction Relative MAO inhibitory potency... [Pg.466]

Table 3). For example, arabinose and xylose differ from ribose only in the orientation of the 2 - and 3 -OH groups yet exhibit markedly different potencies. Whereas 9-(tetrahydrofuryl)-Ade ( SQ 22,536) and 9-(cyclopentyl)-Ade are without hydroxyl groups and are less potent, they offer metabolic and biochemical stability useful for many types of studies. It is, however, the removal of two of the hydroxyl groups, that elicits the largest improvement in inhibitory potency, in particular the 2, 5 -dideoxy- modification (Table 3). With these improvements in potency, these cell permeable compounds, in particular 2, 5 -dd-Ado, have become useful research tools and have been used to inhibit adenylyl cyclases and to lower cAMP levels and alter function in numerous studies in isolated cells or intact tissues. [Pg.34]

Although the 3 - and 5 -polyphosphate derivatives mentioned above exhibit exquisite inhibitory potency these compounds are not cell permeable. To take advantage ofthepotency of such derivatives for studies with intact cells and tissues, there are two possibilities. One is chemically to protect the phosphate groups from exonucleotidases that also allows the compound to transit the membrane intact. The other is to provide a precursor molecule that is cell permeable and is then metabolized into an inhibitor by intracellular enzymes. The general term for such a compound is prodrug nucleotide precursors are also referred to as pronucleotides. Families of protected monophosphate derivatives were synthesized, based on (3-L- and 3-D-2, 5 -dd-3 -AMP, 3-L-2, 3 -dd-5 -AMP, and the acyclic 9-substituted adenines, PMEA and PMPA. Protective substituents were (i) -( -pivaloyl-2-thioethyl) ... [Pg.36]

Besides hydroxyethylamine-based inhibitors, 1,2-dihydroxyethylene-based inhibitors were also explored [58]. Only compoimds with the (R,R,R,R)-configuration at the four central carbon atoms demonstrated any inhibitory potency, and a hydroxyindan substituent at the terminal nitrogen atoms improved activity. Hence (2R,3R,4R,5R)-2,5-bis[(prop-2-en-l-yl)oxy]-3,4-dihydroxy-N, N -bis[(lS,2R)-2-hydroxy-2,3-dihydro-lH-inden-l-yl]hexanediamide was selected for an optimization study ( ipUsmepsini = 163 nM, K =... [Pg.175]

The effect of lactone ring-size on the inhibition was studied, for N-acetyl-)3-D-glucosaminidase from bovine epididymis, with lactones and lactone derivatives unable to undeigo ring-isomerization, by Pokomy and co-workers. From a comparison of Kj values for 2-acetamido-2-deoxy-D-glu-cono-1,5-lactone (0.45 nM) with the 1,4-lactone (4.5 fiM) and of Kj for the methyl ) -furanoside with that for the pyranose (4 mM), it was concluded that the 1,4-lactone has an 10-fold lower inhibitory potency than the 1,5-lactone. The weak inhibition by the 5,6-O-isopropylidene derivative of the... [Pg.330]

The data in Table VI demonstrate that, for most enzymes, 1,5-iminoaldi-tols have an inhibitory potency similar to or even arger than that with... [Pg.336]

The pH-dependence of the inhibition also indicated that unprotonated castanospermine is a better inhibitor than the protonated form. However, as essential carboxyl groups of the enzyme ionize in the same range of pH as castanospermine (pK, 6.09), it was not possible to estimate the inhibitory potency of protonated castanospermine. [Pg.343]

As an illustration of PLS regression (PLSl) we reconsider the inhibitory potencies of oxidative phosphorylation of 11 doubly substituted salicylanilides [ 17] in Table 37.1. An extended Hansch model is defined by the linear free energy relation ... [Pg.410]

FIGURE 4. Correlation between the relative inhibitory potencies of various drugs at high- and low-affinity [ H]MDA binding and between drug lipophilicities and inhibition potencies of [ H]MDA binding... [Pg.230]

E I is a kinetic chimera Kj and kt are the constants characterizing the inactivation process kt is the first-order rate constant for inactivation at infinite inhibitor concentration and K, is the counterpart of the Michaelis constant. The k,/K, ratio is an index of the inhibitory potency. The parameters K, and k, are determined by analyzing the data obtained by using the incubation method or the progress curve method. In the incubation method, the pseudo-first-order constants /cobs are determined from the slopes of the semilogarithmic plots of remaining enzyme activity... [Pg.361]

Kerrigan, J. E. Oleksyszyn, J. Kam, C.-M. Selzler, J. Powers, J. C. Mechanism-based isocoumarin inhibitors of human leucocyte elastase. Effects of the 7-amino substituent and the 3-alkoxy group in 3-alkoxy-7-amino-4-chloroisocoumarins on inhibitory potency. j. Med. Chem. 1995, 38, 544-552. [Pg.382]

The most potent thrombin inhibitor is hirudin, originally isolated from the salivary glands of the medicinal leech Hirudo medicinalis. Its inhibition constant is in the femtomolar (10-15 M) range (57). It is a 65-amino-acid tyrosine-sulfated single-chain polypeptide. Recombinant hirudin differs from native hirudin by the absence of the sulfate group on tyrosine 63 (Tyr-63) and is referred to as desulfato hirudin. The loss of this sulfate group reduces the thrombin inhibitory potency by 10-fold. [Pg.149]

Fig. 53. Mannosylated dendron based on a poly-L-lysine scaffold. This construct leads to subnanomolar inhibitory potency against uropathogenic E. coli,336... Fig. 53. Mannosylated dendron based on a poly-L-lysine scaffold. This construct leads to subnanomolar inhibitory potency against uropathogenic E. coli,336...

See other pages where Inhibitory potency is mentioned: [Pg.466]    [Pg.34]    [Pg.128]    [Pg.130]    [Pg.131]    [Pg.135]    [Pg.135]    [Pg.136]    [Pg.136]    [Pg.137]    [Pg.143]    [Pg.167]    [Pg.33]    [Pg.333]    [Pg.334]    [Pg.342]    [Pg.350]    [Pg.351]    [Pg.82]    [Pg.230]    [Pg.118]    [Pg.135]    [Pg.481]    [Pg.199]    [Pg.255]    [Pg.43]    [Pg.177]    [Pg.200]    [Pg.208]    [Pg.269]    [Pg.276]    [Pg.291]    [Pg.301]    [Pg.302]    [Pg.310]    [Pg.332]    [Pg.342]    [Pg.2]   
See also in sourсe #XX -- [ Pg.217 , Pg.363 ]

See also in sourсe #XX -- [ Pg.11 , Pg.553 ]

See also in sourсe #XX -- [ Pg.33 , Pg.37 , Pg.65 , Pg.67 , Pg.72 , Pg.74 , Pg.75 , Pg.82 , Pg.83 , Pg.85 , Pg.87 , Pg.88 , Pg.103 , Pg.106 , Pg.110 , Pg.113 , Pg.124 , Pg.136 , Pg.137 , Pg.139 , Pg.140 , Pg.143 , Pg.145 , Pg.146 , Pg.147 , Pg.148 , Pg.151 , Pg.153 , Pg.154 , Pg.160 , Pg.161 , Pg.162 , Pg.163 , Pg.164 , Pg.174 , Pg.175 , Pg.180 , Pg.192 , Pg.193 , Pg.194 , Pg.195 , Pg.198 , Pg.199 , Pg.202 , Pg.203 , Pg.210 , Pg.212 , Pg.213 , Pg.217 , Pg.229 ]




SEARCH



Chlorpyrifos inhibitory potency

Chlorpyrifos relative inhibitory potency

Drug development inhibitory potency

Inhibitory Potency Against Plant PDHc

Inhibitory potency, differences

Potency

Quercetin inhibitory potency

Relative inhibitory potency

Structure-inhibitory potency relationship

© 2024 chempedia.info